Pallas Health vs Luvo Health: Which online weight-loss option fits you?

Pallas Health vs Luvo Health: quick verdict first. Pallas publishes clear starting prices, offers clinician-chosen brand or compounded GLP-1s and includes provider care in one plan price. Luvo Health describes ongoing support and dose changes but current pricing, renewal and many details were not published or verified on the captured landing page.

See Pallas Health plans and starting prices

Pallas Health vs Luvo Health: five key differences at a glance

The comparison below focuses on the most distinctive supported differences: pricing transparency, availability of brand-name versus compounded medications, what the plan price covers, state and visit requirements, and regulatory notes about compounded meds. All statements are drawn from the captured evidence for each provider.

1. Pricing transparency and explicit starting costs

Pallas Health: Compounded semaglutide is $139 for the first month, then $597 every 12 weeks (a $199/month average); compounded tirzepatide is $179 first month, then $897 every 12 weeks (a $299/month average). Brand-name Wegovy, Ozempic, Zepbound and Mounjaro are listed as cash-pay monthly figures on the captured page. Pallas states provider care and check-ins are included with no membership fee. Luvo Health: the captured landing-page evidence did not publish verified current pricing or full renewal terms; the site text emphasizes ongoing support, dose changes and that pricing and eligibility are subject to the live offer. Where pricing is important, Pallas provides explicit starting and renewal figures on the captured content while Luvo’s captured content did not verify those numbers.

Compare Pallas pricing and plan details

2. Brand-name options versus compounded preparations

Pallas Health: captured evidence shows clinicians may choose between FDA-approved brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro) and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. Pallas notes compounded medications are prepared by US-licensed compounding pharmacies and are not FDA-approved. Luvo Health: captured content lists tirzepatide injection, semaglutide injection and semaglutide tablets and warns that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA. The captured Luvo evidence did not detail a brand-versus-compounded workflow or explicit brand-name availability like Pallas does on the captured page.

3. What the plan price and care include

Pallas Health: the captured evidence repeatedly states one all-in plan price that includes clinician review, ongoing check-ins and care-team messaging with no membership fee, and a self-serve portal and free companion app. Luvo Health: the captured evidence emphasizes ongoing support and dose changes and says cancel anytime, but it did not capture explicit statements that mirror Pallas’s described all-in plan pricing or the same provider-care inclusions.

4. State rules and visit requirements

Pallas Health: the captured content states Pallas is 100 percent online and asynchronous in most states, with a video visit required in seven states plus Washington, D.C., and asynchronous intake in 43 of 50 states. Luvo Health: the captured evidence notes treatment is available only when a licensed clinician determines it is medically appropriate and that state availability and pharmacy terms may change; specific state-by-state video visit requirements were not published on the captured landing page.

5. Regulatory and refund notes

Both: captured evidence for both providers notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Pallas also captured a specific refund statement: refunded in full if a clinician decides treatment is not right for you. Luvo’s captured landing page included a cancellation and refund policy reference but did not publish the detailed refund language on the captured content.

How to decide: which provider fits your priorities

Use the primary keyword: Pallas Health vs Luvo Health when weighing these tradeoffs. If you need explicit starting prices, clear statements that clinician care is bundled in one plan price, and a captured workflow that lists both brand-name and compounded options chosen by a clinician, the captured evidence favors Pallas Health. If you prefer to confirm live offers, state coverage, renewal terms and exact current costs directly with the provider before enrolling, the captured Luvo Health page instructs you to verify eligibility and pricing with the live offer.

Check Luvo Health eligibility and live offer

Final comparison notes and limitations

All claims above reflect the captured landing-page evidence. Pallas’s captured content includes specific pricing tables and many explicit statements about what is included. Luvo’s captured content repeatedly noted that pricing, eligibility, pharmacy and renewal terms may change and that current details were not published or could not be verified on the captured affiliate landing page. Where evidence is not supplied in the captured content, this article does not infer missing details.

Review Pallas Health eligibility and clinician review

Choose one based on the captured evidence

Choose Pallas Health if you want a clinician to choose between brand-name pens and clinician-personalized compounded preparations with clearly listed starting prices and an all-in plan price that includes provider care. Choose Luvo Health if you will confirm eligibility, medication, total cost, renewal terms and state availability directly with the live offer because those details were not verified on the captured page.

Verify Luvo Health pricing and availability